v3.19.1
CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Cumulative effect of accounting change       $ 5,152 $ (5,152)  
Balance at Dec. 31, 2017 $ 3,727,264 $ 123 $ 3,228,174 846,490 (574,372) $ 226,849
Shares, Outstanding at Dec. 31, 2017   123,245,827        
Net income attributable to Colfax Corporation 24,535     24,535    
Net income attributable to noncontrolling interest 4,507         4,507
Net income 29,042          
Distributions to noncontrolling owners (721)         (721)
Other comprehensive loss, net of tax 77,499       71,447 6,052
Common stock-based award activity 8,160   8,160      
Common stock-based award activity (in shares)   231,908        
Balance at Mar. 30, 2018 3,841,244 $ 123 3,236,334 876,177 (508,077) 236,687
Shares, Outstanding at Mar. 30, 2018   123,477,735        
Cumulative effect of accounting change       15,368 (15,368)  
Balance at Dec. 31, 2018 3,476,946 $ 117 3,057,982 991,838 (780,177) 207,186
Shares, Outstanding at Dec. 31, 2018   117,275,217        
Net income attributable to Colfax Corporation (52,023)     (52,023)    
Net income attributable to noncontrolling interest 4,021         4,021
Net income (48,002)          
Distributions to noncontrolling owners (2,170)         (2,170)
Noncontrolling interest share repurchase (92,721)   (22,409)   (21,372) (48,940)
Other comprehensive loss, net of tax 22,172       18,053 4,119
Issuance of Tangible Equity Units 377,814   377,814      
Common stock-based award activity 7,677 $ 1 7,676      
Common stock-based award activity (in shares)   283,197        
Balance at Mar. 29, 2019 $ 3,741,716 $ 118 $ 3,421,063 $ 955,183 $ (798,864) $ 164,216
Shares, Outstanding at Mar. 29, 2019   117,558,414